Status:
COMPLETED
HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists
Lead Sponsor:
Hospital for Special Surgery, New York
Conditions:
COVID
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The goal of this study is to understand the infectious exposure of SARS-coronavirus 2 (SARS-CoV2) among surgeons and anesthesiologists and to correlate this status with self-reported indices of COVID-...
Eligibility Criteria
Inclusion
- Accredited to practice at HSS
- All anesthesiology and surgery faculty
- All anesthesia and orthopedic surgery fellows
- All orthopedic surgery residents
Exclusion
- • Refusal to participate in either of the interventions at either of the timepoints of interest
Key Trial Info
Start Date :
May 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 4 2020
Estimated Enrollment :
143 Patients enrolled
Trial Details
Trial ID
NCT04389294
Start Date
May 5 2020
End Date
September 4 2020
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Special Surgery
New York, New York, United States, 10021